RISK OF SYSTEMIC METASTASES IN CLINICAL STAGE I NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTION
Author:
Affiliation:
1. From the Department of Urology, Indiana University Medical Center, Indianapolis, Indiana
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference23 articles.
1. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone;Freedman;Lancet,1987
2. Identifying patients with low-risk, clinical stage I nonseminomatous testicular tumors who should be treated by surveillance;Wishnow;Urology,1989
3. Treatment decision for stage I non-seminomatous germ cell tumors based on the risk factor “vascular invasion.”;Hoeltl;Br J Urol,1992
4. Primary retroperitoneal lymph node dissection in clinical stage A nonseminomatous germ cell testis cancer. Review of the Indiana University experience 1965–1989;Donohue;Br J Urol,1993
5. Medical Research Council prospective study of surveillance for stage I testicular teratoma;Read;J Clin Oncol,1992
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection;Clinical Genitourinary Cancer;2024-09
2. Comparison of the perioperative outcomes of laparoscopic and open retroperitoneal lymph node dissection for low-stage (stage I/II) testicular germ cell tumors: a systematic review and meta-analysis;International Journal of Surgery;2023-03-14
3. Biomarkers of disease recurrence in stage I testicular germ cell tumours;Nature Reviews Urology;2022-08-26
4. Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review;World Journal of Urology;2022-07-29
5. Post-treatment Residual Clinicopathological Outcomes in Testicular Germ Cell Tumours;Indian Journal of Surgical Oncology;2022-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3